Inflitza 25mg Capsule

Composition Midostaurin (25mg)
Rx Prescription Required
Pack strip of 4 capsules
Storage None
Chemical Class Indolocarbazoles
Action Class Topical Bacterial Protein Synthesis Inhibitors
Habbit Forming
Manufacturer Intas Pharmaceuticals Ltd
Manufacturer address Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India.

Inflitza 25mg Capsule is a medicine used in the treatment of blood cancer (acute myeloid leukemia). It works by stopping the cancer cells from growing and multiplying. This way it stops the growth and spread of the cancer in the body and helps in disease management.

Inflitza 25mg Capsule is best taken with food. This will reduce the risk of nausea and vomiting. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, vomiting, headache, musculoskeletal pain, nosebleed, hyperglycemia, and upper respiratory tract infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You have to avoid driving or attention seeking activity if you experience dizziness while taking this medicine.

Before taking it, tell your doctor if you have any other preexisting medical conditions or taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Treatment of (Acute Myeloid Leukemia) Blood cancer

Take this medicine in the dose and duration as advised by your doctor. Inflitza 25mg Capsule is to be taken with food.

Inflitza 25mg Capsule works by blocking the action of the abnormal protein that triggers the multiplication of cancer cells. This helps stop the spread of mast and cancer cells.

Q: What if you forget to take this medicine?
A:

Take Inflitza 25mg Capsule exactly as your doctor tells you.

Your doctor may prescribe medicines to help prevent the nausea and vomiting during treatment with Inflitza 25mg Capsule.

Take Inflitza 25mg Capsule with food.

Do not take Inflitza 25mg Capsule for a condition for which it was not prescribed. Do not give Inflitza 25mg Capsule to other people, even if they have the same condition or symptoms you have. It may harm them.

In Treatment of (Acute Myeloid Leukemia) Blood cancer

Inflitza 25mg Capsules helps treat a type of blood cancer called acute myeloid leukemia (AML). It stops certain enzymes from making the cancer cells grow and multiply. This medicine controls the cancer cell multiplication and improves disease management. It’s often used with other treatments like chemotherapy. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

Febrile neutropenia

Nausea

Mucositis

Vomiting

Headache

Petechiae (red or purple spot caused by bleeding into the skin)

Musculoskeletal (bone, muscle or joint) pain

Nosebleeds

Infection

Increased glucose level in blood

Upper respiratory tract infection

Alcohol:CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Inflitza 25mg Capsule. Please consult your doctor.

Pregnancy:CONSULT YOUR DOCTOR

Inflitza 25mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding:CONSULT YOUR DOCTOR

Inflitza 25mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving:CONSULT YOUR DOCTOR

It is not known whether Inflitza 25mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney:SAFE IF PRESCRIBED

Inflitza 25mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Inflitza 25mg Capsule may not be needed in these patients. Please consult your doctor.

Liver:SAFE IF PRESCRIBED

Inflitza 25mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Inflitza 25mg Capsule may not be needed in these patients. Please consult your doctor.